news.alphastreet.comOCT 62 min read$STZ

Constellation Brands’ Q2 FY27 Earnings Rise, Beat Estimates

Constellation Brands (STZ) reported Q2 FY27 adjusted earnings of $3.74 per share, up from $3.63, beating estimates. Net sales rose to $2.63B from $2.48B, with 6% organic growth. FY27 EPS guidance is $11.85–$12.55 (reported) and $11.20–$11.90 (comparable).

Original reporting

news.alphastreet.com

Published Oct 6, 2026, 8:20 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 7, 2026, 2:33 AM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefEarnings

Primary signal

$STZ

Bullish

high confidence

Mentioned

$STZ

Relevance

9/10

AlphAI data visualization · based on news.alphastreet.com

Decision brief

The 30-second read

$STZBullishHigh

Why it matters

Earnings beat and raised FY guidance suggest stronger demand and pricing power.

Market read

The earnings surprise and guidance raise expectations for the stock and its sector.

What to watch

Potential headwinds from input cost inflation or regulatory changes.

Relevance 9/10Novelty 9/10Timing: post-market

Background

Constellation Brands (STZ) is a leading beverage company with brands in beer, wine, and spirits.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$STZBullishHigh confidence

Context

Constellation Brands reported Q2 FY27 adjusted earnings of $3.74 per share, beating estimates and raised FY guidance.

Expected impact

upward pressure as market prices in the earnings beat and higher guidance

Evidence & confidence

The beat and guidance lift expectations for future earnings, prompting buying interest.

Market effects

Sector

Strong performance may boost the broader alcoholic beverage sector.

Regional

Positive for U.S. consumer discretionary stocks.

Global

Limited to markets tracking U.S. consumer staples.

Counterpoint

What could challenge this read

If guidance falls short of analyst expectations, the rally could be short-lived.

Key entities

Executive
Nicholas Fink
CEO of Constellation Brands who commented on growth outlook.

Read at source ← All news

NOV 2

$STZMed

Jefferies raises Constellation Brands stock price target on beer margin outlook

Jefferies raised its price target for Constellation Brands (STZ) to $142 from $135, maintaining a Hold rating. The firm cited improved beer margin outlook and recent share gains. STZ's P/E ratio is 12.09, with a PEG ratio of 0.19. The company reported Q2 net sales of $2.63B, up 6% YoY, with EPS of $3.74. Other analysts have mixed outlooks.

investing.com2 min

OCT 31

$STZMed

Judge keeps distribution deal in place after Coors warns of nine-figure losses

A Denver judge blocked Constellation Brands from canceling its distribution deal with Coors Distributing Company (CDC), a subsidiary of Molson Coors, citing potential $100M+ losses and reputational harm. CDC claims the deal is worth over nine figures. Constellation disputes CDC's claims. A hearing on CDC's lawsuit against Mark Anthony Brands is scheduled.

denverpost.com2 min

OCT 12

$STZMedAI 8/10

Constellation Brands Agrees to Buy SpikedAde for Up to $353 Million

Constellation Brands (STZ) agreed to buy SpikedAde for up to $353M, entering the 'hard hydration' alcohol segment. The deal follows Q2 results showing beer sales growth but softer retail demand. CEO Nick Fink aims to diversify, though past acquisitions have underperformed. Analysts note the deal's manageable size but caution about the category's long-term potential.

vinetur.com7 min

OCT 12

$STZMedAI 8/10

Constellation Brands reports a 26% drop in first-half wine and spirits sales

Constellation Brands reported a 26% drop in wine and spirits net sales to $308.6M for the first half of its fiscal year, largely due to 2025 divestitures. Organic sales in the segment grew 12%. Group net sales rose 1% to $5.066B, with beer sales up 4% to $4.757B. Net income increased 24% to $1.220B. The company maintained a cautious outlook for the rest of the year.

vinetur.com2 min

OCT 11

$STZHighAI 8/10

Constellation Brands: Q2 Revenue Rises 6% To $2.63 Billion As Beer And Wine And Spirits Sales Grow

Constellation Brands reported Q2 fiscal 2027 net sales of $2.63B, up 6% YoY. Beer sales rose 5% to $2.47B, while Wine and Spirits sales increased 17% to $159.4M. Operating income fell 8% to $805M, but EPS rose 25% to $3.32. The company acquired SpikedAde for $75M, with up to $278M in contingent payments. Constellation updated its fiscal 2027 EPS guidance to $11.85-$12.55 and declared a $1.03 quarterly dividend.

pulse2.com3 min

OCT 9

$LWLow

Earnings market review: beats fall short as guidance and costs drive reactions

Lamb Weston (LW) and Constellation Brands (STZ) reported earnings beats but faced mixed reactions due to guidance and cost pressures. PepsiCo (PEP) and Delta Air Lines (DAL) also reported, with DAL missing EPS estimates. Analysts note that estimate revisions, not just beats, are driving market reactions. The macro backdrop includes high yields and expensive oil, impacting earnings expectations.

uk.investing.com3 min